These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 25268204)

  • 1. [Modern anti-cancer therapy: current state and future developments].
    Bokemeyer C; Hiddemann W
    Dtsch Med Wochenschr; 2014 Oct; 139(41):2067. PubMed ID: 25268204
    [No Abstract]   [Full Text] [Related]  

  • 2. [Targeted therapy: old and new possibilities].
    Hochhaus A; Lüftner D; Mackensen A
    Onkologie; 2013; 36 Suppl 5():2-11. PubMed ID: 23921800
    [No Abstract]   [Full Text] [Related]  

  • 3. Development trends for monoclonal antibody cancer therapeutics.
    Reichert JM; Valge-Archer VE
    Nat Rev Drug Discov; 2007 May; 6(5):349-56. PubMed ID: 17431406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimising translational oncology in clinical practice: strategies to accelerate progress in drug development.
    Stahel R; Bogaerts J; Ciardiello F; de Ruysscher D; Dubsky P; Ducreux M; Finn S; Laurent-Puig P; Peters S; Piccart M; Smit E; Sotiriou C; Tejpar S; Van Cutsem E; Tabernero J
    Cancer Treat Rev; 2015 Feb; 41(2):129-35. PubMed ID: 25533737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted drugs in combination with radiotherapy for the treatment of solid tumors: current state and future developments.
    Selzer E; Kornek G
    Expert Rev Clin Pharmacol; 2013 Nov; 6(6):663-76. PubMed ID: 24164614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Personalizing oncology: perspectives and prospects.
    Mendelsohn J
    J Clin Oncol; 2013 May; 31(15):1904-11. PubMed ID: 23589547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. X chemotherapy, myth and realities.
    Thomas M; Pavithran K
    J Indian Med Assoc; 2005 Sep; 103(9):489-90, 492, 494. PubMed ID: 16493871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted immunotherapies overtaking emerging oncology market value based growth.
    Jakovljevic MB
    J BUON; 2015; 20(1):350-1. PubMed ID: 25778340
    [No Abstract]   [Full Text] [Related]  

  • 9. Targeted and tailored therapy in hemato-oncology: vision for the 21st century.
    Shpilberg O; Ben-Bassat I; Raanani P
    Isr Med Assoc J; 2006 Dec; 8(12):843-4. PubMed ID: 17214100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New targets and targeted drugs for the treatment of cancer: an outlook to pediatric oncology.
    Rossig C; Juergens H; Berdel WE
    Pediatr Hematol Oncol; 2011 Oct; 28(7):539-55. PubMed ID: 21936619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Advances in medical oncology].
    Shi YK
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):305-10. PubMed ID: 16900620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New drugs in oncology: benefits, risks and challenges].
    Cella D; Vervölgyi V; Wörmann B
    Onkologie; 2013; 36 Suppl 5():12-9. PubMed ID: 23921801
    [No Abstract]   [Full Text] [Related]  

  • 13. The RACE to accelerate drug development for children with cancer.
    Pearson ADJ; Karres D; Reaman G; DuBois SG; Knox L; Scobie N; Vassal G
    Lancet Child Adolesc Health; 2020 Oct; 4(10):714-716. PubMed ID: 32822672
    [No Abstract]   [Full Text] [Related]  

  • 14. ASCO 2011: broadening the horizons of cancer research.
    Crane K
    J Natl Cancer Inst; 2011 Jul; 103(13):999-1001. PubMed ID: 21693729
    [No Abstract]   [Full Text] [Related]  

  • 15. Targeted biopharmaceuticals for cancer treatment.
    Zhou L; Xu N; Sun Y; Liu XM
    Cancer Lett; 2014 Oct; 352(2):145-51. PubMed ID: 25016064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dermatology -- the most progressive discipline in medicine].
    Röcken M
    J Dtsch Dermatol Ges; 2015 Jul; 13(7):617-9. PubMed ID: 26110720
    [No Abstract]   [Full Text] [Related]  

  • 17. [Status quo and prospects for systemic therapy of atopic dermatitis. Biologics ante portas].
    Biedermann T; Werfel T
    Hautarzt; 2015 Feb; 66(2):108-13. PubMed ID: 25645542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The next generation of antibody-drug conjugates comes of age.
    Beck A; Haeuw JF; Wurch T; Goetsch L; Bailly C; Corvaïa N
    Discov Med; 2010 Oct; 10(53):329-39. PubMed ID: 21034674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Targeted based therapies in metastatic breast cancer: future evolution].
    Belmondo L; Montana M; Curti C; Crozet M; Rathelot P; Penot-Ragon C; Vanelle P
    Therapie; 2012; 67(6):491-503. PubMed ID: 23249575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced non-small-cell lung cancer: new data, therapy choices, and challenging decisions.
    Sandler AB
    Oncology (Williston Park); 2006 May; 20(6):626-8. PubMed ID: 16773846
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.